Diana Brainard - 03 Oct 2024 Form 4 Insider Report for Allovir, Inc. (KLRS)

Role
Chief Executive Officer, Director
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Issuer symbol
KLRS
Transactions as of
03 Oct 2024
Net transactions value
-$1,216
Form type
4
Filing time
04 Oct 2024, 16:15:04 UTC
Previous filing
22 Aug 2024
Next filing
23 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale $1,216 -1,493 -0.2% $0.8148 752,430 03 Oct 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.